Wow, $124m US combined and further double digit royalties on net sales!
And based on peak sales of $500m combined US/Europe x5 countries.
Neu have this forecast in US licensing alone with potential patients 10,000. (5,000 identified)
ROW license has potential patents 50,000 (7,000 identified)
Peak sales in ROW licence for Neu could be at least double US @ $1B+, maybe 4-5 times US market.
Ann: Neuren appoints Vice President, Corporate Development, page-16
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |